Can
Amino Acids Sing?
An Australian
scientist may have found how and why amino acids fold into certain sequences--leading
to possible novel new drug treatments. At Monash University in Melbourne,
associate professor Irena Cosic has developed this unique approach to drug
design.
Biochemical
reactions in living organisms are all controlled by biological catalysts
or regulators, and most of these are proteins. It has long been known
that proteins depend on their three-dimensional shape for their action.
That shape, in turn, depends on protein structure.
Proteins
are long chains made of sequentially linked simpler molecules known as
amino acids. This sequence ultimately determines the three-dimensional
shape into which the protein will fold, as well as its activity.
But exactly how protein shape and function emerge from the sequencing of
amino acids has been the subject of laborious research, which until now
has produced no great leap forward.
As
an engineer, Dr. Cosic decided to approach the problem mathematically--she
decided to represent every amino acid in the sequence with a number, as
a measure of each amino acid's ability to interact to determine this measure,
Dr. Cosic used an estimate of the energy of the most loosely bound electrons
of each of the 20 naturally occurring amino acids. These electrons are
at the heart of chemical interaction.
Having
represented a protein sequence by a string of numbers, she could then draw
a graph of the number sequence of amino acids along a protein. Not
surprisingly, what emerged looked like a spiky squiggle. But to an
electrical engineer like Dr. Cosic, such squiggles looked like signal sand
an invitation to investigate further.
When
electrical engineers analyze complex signals--such as the trace of a heartbeat
or radio waves from outer space--they break them down into a series of
regular wavelike curves which, when added together, recreate the original
signal. Each component wave has a frequency measured in hertz, the
number of times the wave form is repeated each second.
Dr.
Cosic was able to take whole protein sequences and graph the contribution
of each component wave form against its frequency. She then compared
the results for groups of proteins which performed a similar function and
for proteins which performed different functions.
What
emerged was astounding. Among their component waves, proteins which
performed the same function--a group of growth factors, for example--all
possessed one waveform in common, a single characteristic frequency which
they shared. In contrast, proteins which were unrelated in function
shared no such frequency. What is more, the characteristic frequencies
were different for groups of proteins performing different functions.
Even
more astonishing was that when Dr. Cosic analyzed the target molecules
which interact with proteins--the receptors to which a group of proteins
bind, for instance--she found that the characteristic frequency of the
protein group matched that of its target.
"They
recognize each other on the bias of frequency. It's very obvious
to an electrical engineer. It's like tuning into a radio station."
Dr.
Cosic then explored the possibility that electromagnetic waves of the right
frequency levels could be produced by electron movement along proteins.
When she calculated such movement theoretically, she found the energy frequencies
were typical of visible light. So she investigated groups of light-sensitive
proteins, comparing the values she calculated for their characteristic
frequencies with the frequency of the light ot which they were sensitive.
Sure enough, the values matched.
But
the ultimate test of any scientific hypothesis is prediction. She
reasoned that if her theory was correct, and the action of group of functionally
similar proteins was related to their characteristic frequency, it should
be possible to mimic that action by designing a sequence of amino acids
with the same characteristic frequency.
And
this is just what Dr. Cosic has done. The first group of proteins
she chose was on the outside coating of the human immunodeficiency virus
(HIV). After calculating the characteristic frequency of these proteins,
she designed a totally unrelated amino acid sequence ot match that frequency.
The sequence was constructed and tested at the Universite de Lyon in France.
It was found that the newly designed amino acid sequence could trigger
the immune system to recognize HIV. As such, the sequence might be
useful as the basis of a vaccine.
Dr.
Cosic, who came to Australia from her native Serbia in 1989, is currently
deputy head of Monash's Electrical and Computer Systems Engineering department.
She is also the author of the recently published The Resonant Recognition
Model of Micromolecular Bioactivity.